Medtronic (NYSE:MDT) reported its fiscal 4th quarter and 2013 results this morning, posting profit declines for both periods on slight sales growth and beating Wall Street’s expectations for earnings per share.
MassDevice Earnings Roundup
Covidien restates Q2 financials ahead of pharma spinout | Wall Street Beat
Covidien (NYSE:COV) re-stated its financial results for the fiscal 3rd quarter ended March 29, in anticipation of the planned spinout of its Mallinckrodt pharmaceuticals business next month.
Covidien said the new numbers reflect the pharma unit as a discontinued operation, with COV shareholders slated to receive a tax-free distribution, according to a regulatory filing.
Natus Medical’s Q1 profits soar 1000%
Natus Medical (NSDQ:BABY) reported a 1,000% increase in profits during the 1st quarter, handily beating Wall Street’s earnings-per-share forecast in the process.
Mindray Medical slides on missed Q1 earnings, bounces back
Biolase gets FDA nod for new tissue laser
Biolase (NSDQ:BIOL) won 510(k) clearance from the FDA for its WaterLase iPlus, a laser used for soft-tissue orthopedic procedures.
The clearance opens up a $2.6 billion market opportunity for the WaterLase device, according to a company statement.
Dentsply lowers 2013 guidance
Dentsply International (NSDQ:XRAY) boosted profits 35% during the 1st quarter but lowered its 2013 guidance to account for worsening market conditions in the European Union.
